These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2031076)

  • 1. Low-dose cyclopenthiazide in the treatment of hypertension: a one-year community-based study.
    Johnston GD; Wilson R; McDermott BJ; McVeigh GE; Duffin D; Logan J
    Q J Med; 1991 Feb; 78(286):135-43. PubMed ID: 2031076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The case for low dose diuretics in hypertension: comparison of low and conventional doses of cyclopenthiazide.
    McVeigh G; Galloway D; Johnston D
    BMJ; 1988 Jul; 297(6641):95-8. PubMed ID: 3044503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antihypertensive and metabolic effects of low and conventional dose cyclopenthiazide in type II diabetics with hypertension.
    Passmore AP; Whitehead EM; Crawford V; McVeigh GE; Johnston GD
    Q J Med; 1991 Nov; 81(295):919-28. PubMed ID: 1808632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low and conventional dose cyclopenthiazide on glucose and lipid metabolism in mild hypertension.
    McVeigh GE; Dulie EB; Ravenscroft A; Galloway DB; Johnston GD
    Br J Clin Pharmacol; 1989 Apr; 27(4):523-6. PubMed ID: 2655692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of low versus conventional dose cyclopenthiazide on platelet intracellular calcium in mild essential hypertension.
    McVeigh GE; Copeland S; McKellar J; Johnston D
    J Hypertens; 1988 Apr; 6(4):337-41. PubMed ID: 3288695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the haemodynamic and hormonal effects of low and conventional dose cyclopenthiazide in normal volunteers.
    McVeigh GE; McMaster M; Linton T; Whitehead E; Johnston GD
    Eur J Clin Pharmacol; 1990; 38(4):351-7. PubMed ID: 2188845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xipamide and cyclopenthiazide in essential hypertension--comparative effects on blood pressure and plasma potassium.
    MacGregor GA; Banks RA; Markandu ND; Roulston J
    Br J Clin Pharmacol; 1982 Jun; 13(6):859-63. PubMed ID: 7046777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative clinical trial of bemetizide/triamterene and cyclopenthiazide/potassium chloride combinations in patients with mild to moderate hypertension.
    Wray R; Benton KG; Whitehill D; Wright B; Weener W; Whittington JR
    Curr Med Res Opin; 1983; 8(9):665-74. PubMed ID: 6365467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of tienilic acid with cyclopenthiazide in hyperuricaemic hypertensive patients.
    Bolli P; Simpson FO; Waal-Manning HJ
    Lancet; 1978 Sep; 2(8090):595-8. PubMed ID: 80525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of equivalent antihypertensive doses of mefruside and cyclopenthiazide on serum electrolytes, uric acid and glucose tolerance in hypertensive patients.
    Waal-Manning HJ
    Clin Exp Pharmacol Physiol; 1975; 2(2):141-6. PubMed ID: 1095262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group.
    Savage PJ; Pressel SL; Curb JD; Schron EB; Applegate WB; Black HR; Cohen J; Davis BR; Frost P; Smith W; Gonzalez N; Guthrie GP; Oberman A; Rutan G; Probstfield JL; Stamler J
    Arch Intern Med; 1998 Apr; 158(7):741-51. PubMed ID: 9554680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
    Lee IT; Hung YJ; Chen JF; Wang CY; Lee WJ; Sheu WH
    Clin Ther; 2012 Aug; 34(8):1735-50. PubMed ID: 22784975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a sustained-release formulation of oxprenolol and cyclopenthiazide ('Trasidrex') in the management of hypertension: a general practice study.
    Forrest WA
    Curr Med Res Opin; 1980; 6(8):559-63. PubMed ID: 7389387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the effects of low- and conventional-dose thiazide diuretic on insulin action in hypertensive patients with NIDDM.
    Harper R; Ennis CN; Heaney AP; Sheridan B; Gormley M; Atkinson AB; Johnston GD; Bell PM
    Diabetologia; 1995 Jul; 38(7):853-9. PubMed ID: 7556989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive treatment with candesartan cilexetil does not affect glucose homeostasis or serum lipid profile in patients with mild hypertension and type II diabetes.
    Trenkwalder P; Dahl K; Lehtovirta M; Mulder H
    Blood Press; 1998 May; 7(3):170-5. PubMed ID: 9758087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of piretanide capsules on blood pressure during ergometric and isometric work loads in patients with mild to moderate essential hypertension.
    Meywald W; Maass L; Verho M; Rangoonwala B
    Pharmatherapeutica; 1985; 4(6):356-66. PubMed ID: 4080753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in selected metabolic parameters in patients over 65 receiving hydrochlorothiazide plus amiloride, atenolol or placebo in the MRC elderly trial.
    Damian DJ; McNamee R; Carr M
    BMC Cardiovasc Disord; 2016 Oct; 16(1):188. PubMed ID: 27716064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do all diuretics have equal hypotensive efficacy?
    Jaffe G; Grimshaw JJ; Gay J; Hossain M
    Curr Med Res Opin; 1982; 8(2):75-81. PubMed ID: 7105826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.
    Frias JP; Nauck MA; Van J; Kutner ME; Cui X; Benson C; Urva S; Gimeno RE; Milicevic Z; Robins D; Haupt A
    Lancet; 2018 Nov; 392(10160):2180-2193. PubMed ID: 30293770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
    Florakis D; Hung V; Kaltsas G; Coyte D; Jenkins PJ; Chew SL; Grossman AB; Besser GM; Monson JP
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):453-9. PubMed ID: 11012570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.